Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Reported side effects The side effects reported in trials and research protocols tend to be mild and transient: Common: Injection site reactions: redness, swelling, mild irritation at the injection location Headache: reported in some subjects, typically mild and temporary Mild gastrointestinal discomfort: occasional reports of nausea or upset stomach Less common: Temporary dizziness Slight increases in heart rate Minor liver enzyme elevations in some subjects These effects, when they occur, generally resolve without intervention and don't require discontinuation
Applications in Research Investigation of one-carbon metabolism and methylation pathways Study of cofactor-dependent enzymatic reactions Cellular metabolism and mitochondrial function research Nutrient transport and vitamin uptake studies Reference compound in biochemical and nutritional research Handling Handle using standard laboratory precautions No reconstitution required supplied as a ready-to-use sterile solution Protect from light at all times Do not freeze
Based on current clinical evidence, the rough ordering from largest to smallest weight-loss effect is: Tirzepatide highest average weight loss Semaglutide significant weight loss Tesamorelin moderate weight loss, primarily through visceral fat reduction AOD-9604 primarily body composition effects MOTS-c primarily metabolic and energy effects rather than pure weight reduction AOD-9604 and MOTS-c are generally not considered replacements for GLP-1 medications in patients seeking substantial weight reduction
Always use gentle swirling motions instead
